Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
The New England Journal of Medicine
|
January 18, 2005
Clinical trial registration
Ludovic Reveiz, Andres Felipe Cardona, Edgar Guillermo Ospina
Expert Opinion on Medical Diagnostics
|
March 19, 2013
Molecular biomarkers for predicting chemotherapy response in lung cancer
Jia Wei, Baorui Liu, Andres Felipe Cardona, et al.
Journal of Clinical Epidemiology
|
June 13, 2006
An e-mail survey identified unpublished studies for systematic reviews
Ludovic Reveiz, Andres Felipe Cardona, Edgar Guillermo Ospina, et al.
Cancers
|
April 30, 2021
Small Cell Lung Cancer: State of the Art of the Molecular and Genetic Landscape and Novel Perspective
Valeria Denninghoff, Alessandro Russo, Diego de Miguel-Pérez, et al.
Expert Review of Respiratory Medicine
|
August 15, 2019
Characterising acquired resistance to erlotinib in non-small cell lung cancer patients
Niki Karachaliou, Jordi Codony-Servat, Jillian Wilhelmina Paulina Bracht, et al.
Ebiomedicine
|
November 27, 2018
Integrin-linked kinase (ILK) and src homology 2 domain-containing phosphatase 2 (SHP2): Novel targets in EGFR-mutation positive non-small cell lung cancer (NSCLC)
Niki Karachaliou, Andres Felipe Cardona, Jillian Wilhelmina Paulina Bracht, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 18, 2022
Lung Cancer in Colombia
Andres Felipe Cardona, Sergio A Mejía, Lucia Viola, et al.
Cancer Research Communications
|
December 28, 2025
Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022
Luís Felipe Leite, Lucas Diniz da Conceição, Erick F Saldanha, et al.
Ebiomedicine
|
February 14, 2018
Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-smallcell Lung Cancer Associated With Poor Prognosis
Niki Karachaliou, Imane Chaib, Andres Felipe Cardona, et al.
Journal of the National Cancer Institute
|
April 5, 2017
Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC
Imane Chaib, Niki Karachaliou, Sara Pilotto, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
The New England Journal of Medicine
|
January 18, 2005
Clinical trial registration
Ludovic Reveiz, Andres Felipe Cardona, Edgar Guillermo Ospina
Expert Opinion on Medical Diagnostics
|
March 19, 2013
Molecular biomarkers for predicting chemotherapy response in lung cancer
Jia Wei, Baorui Liu, Andres Felipe Cardona, et al.
Journal of Clinical Epidemiology
|
June 13, 2006
An e-mail survey identified unpublished studies for systematic reviews
Ludovic Reveiz, Andres Felipe Cardona, Edgar Guillermo Ospina, et al.
Cancers
|
April 30, 2021
Small Cell Lung Cancer: State of the Art of the Molecular and Genetic Landscape and Novel Perspective
Valeria Denninghoff, Alessandro Russo, Diego de Miguel-Pérez, et al.
Expert Review of Respiratory Medicine
|
August 15, 2019
Characterising acquired resistance to erlotinib in non-small cell lung cancer patients
Niki Karachaliou, Jordi Codony-Servat, Jillian Wilhelmina Paulina Bracht, et al.
Ebiomedicine
|
November 27, 2018
Integrin-linked kinase (ILK) and src homology 2 domain-containing phosphatase 2 (SHP2): Novel targets in EGFR-mutation positive non-small cell lung cancer (NSCLC)
Niki Karachaliou, Andres Felipe Cardona, Jillian Wilhelmina Paulina Bracht, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 18, 2022
Lung Cancer in Colombia
Andres Felipe Cardona, Sergio A Mejía, Lucia Viola, et al.
Cancer Research Communications
|
December 28, 2025
Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022
Luís Felipe Leite, Lucas Diniz da Conceição, Erick F Saldanha, et al.
Ebiomedicine
|
February 14, 2018
Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-smallcell Lung Cancer Associated With Poor Prognosis
Niki Karachaliou, Imane Chaib, Andres Felipe Cardona, et al.
Journal of the National Cancer Institute
|
April 5, 2017
Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC
Imane Chaib, Niki Karachaliou, Sara Pilotto, et al.
Page
of 2